Results 361 to 370 of about 626,622 (390)
Some of the next articles are maybe not open access.
Apixaban and dalteparin in active malignancy‐associated venous thromboembolism: The ADAM VTE trial
Journal of Thrombosis and Haemostasis, 2020Low‐molecular‐weight heparin is the guideline‐endorsed treatment for cancer‐associated venous thromboembolism (VTE). While apixaban is approved for the treatment of acute VTE, limited data support its use in cancer patients.
R. McBane +16 more
semanticscholar +1 more source
Venous Thromboembolism in Malignancy and Malignancy in Venous Thromboembolism
Pathophysiology of Haemostasis and Thrombosis, 1998The activation of coagulation in patients with cancer contributes significantly to morbidity and mortality rates and may play a fundamental role in the host response to growing tumours. Patients with cancer are clearly at high risk for the development of venous thromboembolism (VTE), particularly during chemotherapy and surgery.
Frederick R. Rickles, Mark Levine
openaire +2 more sources
DeckerMed Medicine, 2020
Venous thromboembolism, which involves venous thrombosis and pulmonary embolism, is a leading cause of morbidity and mortality in hospitalized patients and is being seen with increasing frequency in outpatients. This chapter discusses the risk factors, etiology, classification, pathophysiology, natural history, prognosis, diagnosis (including venous ...
openaire +1 more source
Venous thromboembolism, which involves venous thrombosis and pulmonary embolism, is a leading cause of morbidity and mortality in hospitalized patients and is being seen with increasing frequency in outpatients. This chapter discusses the risk factors, etiology, classification, pathophysiology, natural history, prognosis, diagnosis (including venous ...
openaire +1 more source
Cancer and Venous Thromboembolism
Seminars in Thrombosis and Hemostasis, 2006The evidence of the important two-way clinical correlation between cancer and venous thromboembolism (VTE) dates back to Trousseau's time. Over time it has been established that cancer patients not only exhibit a higher risk of developing VTE when compared with noncancer patients, but also that VTE, especially in its idiopathic presentation, sometimes ...
Piccioli A +4 more
openaire +3 more sources
Diagnosis and Treatment of Lower Extremity Venous Thromboembolism: A Review.
Journal of the American Medical Association (JAMA), 2020Importance Incidence rates for lower extremity deep vein thrombosis (DVT) range from 88 to 112 per 100 000 person-years and increase with age. Rates of recurrent VTE range from 20% to 36% during the 10 years after an initial event.
R. Chopard, I. Albertsen, G. Piazza
semanticscholar +1 more source
Venous Thromboembolism in Children
Hematology/Oncology Clinics of North America, 2008With improved pediatric survival from serious underlying illnesses, greater use of invasive vascular procedures and devices, and a growing awareness that vascular events occur among the young, venous thromboembolism (VTE) increasingly is recognized as a critical pediatric concern.
Neil A. Goldenberg, Timothy J. Bernard
openaire +5 more sources
Treatment of venous thromboembolism
International Journal of Hematology, 2000The combination of heparin and oral anticoagulants has been the treatment of choice for most patients with venous thromboembolism in the last two decades. Heparin has been proven to be effective when administered by intravenous continuous infusion or by subcutaneous injection. Oral anticoagulants should be started at the same time and heparin should be
openaire +6 more sources
Pathogenesis of venous thromboembolism
Current Opinion in Pulmonary Medicine, 2002Three factors are related with the pathogenesis of venous thrombosis: (1) blood stasis, (2) hypercoagulability, and (3) vessel damage. Local and systemic factors are implicated in blood stasis. Remarkable advances have been recently achieved regarding the understanding of the concept of hypercoagulability, with special emphasis to thrombophilic ...
BECATTINI, Cecilia, AGNELLI, Giancarlo
openaire +4 more sources
Pregnancy and venous thromboembolism
Current Opinion in Obstetrics & Gynecology, 2014This review provides a concise and complete overview of diagnostic work-up and treatment of venous thromboembolism in pregnancy, with attention to recent research developments and recent applicable guidelines. This may be useful for all the players of the multidisciplinary interaction needed in this disease management, namely cardiologists and ...
Ralli E, Zezza L, Caserta D.
openaire +2 more sources
Olanzapine and venous thromboembolism
International Clinical Psychopharmacology, 2003Clozapine has recently been associated with venous thromboembolism. The aim of this study was to describe three elderly patients in whom olanzapine therapy was associated with venous thromboembolism. During a 4-month period at the same psychogeriatric clinic, three elderly patients (an 89-year-old male, a 78-year-old male and an 83-year-old female ...
Per Tätting +2 more
openaire +2 more sources